Clé Jeux News Page 5

This page shows you the latest news items in this category. This is page number 5.

Total 88 results found since Jan 2013.

Minimum clearance offsets for providing desired stopping sight distances at simple curves with variable operating speeds - Mauga T.
Lateral clearance on the inside of horizontal curves is required by all geometric design guidelines in order to provide at least stopping sight distance. There already exist graphical models, analytical models, and design charts for determining minimum cle...
Source: SafetyLit - July 28, 2016 Category: Global & Universal Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Author Of ‘The 100’ Series On The Centuries-Long History Of Dystopias
http://huffingtonpost.tumblr.com/post/147052717635/new-leaf-with-huffpost-editor-maddie-crum-features Kass Morgan studied 19th-century literature at Oxford, but her popular “The 100” series, which has been adapted into a show on The CW, isn’t exactly a marriage plot. The three books ― with a fourth due out in December ― center on a space colony that’s suffering from a food shortage and consequently punishes even minor crime-committing adults with death sentences. Teens, on the other hand, are held captive in a prison, until 100 of them are selected to return to Earth to examine whether its ...
Source: Science - The Huffington Post - July 8, 2016 Category: Science Source Type: news

Multiple Lupus Types Raise Risk for CV Disease (CME/CE)
(MedPage Today) -- Local chronic inflammation in CLE and SLE may drive vascular events
Source: MedPage Today Rheumatology - June 14, 2016 Category: Rheumatology Source Type: news

FDA clears Mauna Kea’s Cellvizio Confocal miniprobes
Mauna Kea (ENT:MKEA) said today it won 510(k) clearance from the FDA for its Confocal miniprobes designed for use with the company’s Cellvizio platform. The newly-cleared Confocal miniprobes are indicated for use in urological and minimally invasive surgical applications along with the near-infared Cellvizio platform, Mauna Kea said. The company touted the regulatory win as its 12th in the U.S. “This FDA clearance is another step forward in expanding the utility of the Cellvizio platform in minimally invasive surgery and urological applications. Our near-infrared imaging products are designed to provide a posi...
Source: Mass Device - May 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Mauna Kea Technologies Source Type: news

Psychiatric manifestations by prions. A narrative review - Carrillo Robles D, García Maldonado G.
Prion diseases are a group of rare and rapidly progressive neurodegenerative conditions that may cause neuropsychiatric symptoms. This group of diseases has been described since the 18(th) century, but they were recognized decades later, when it became cle...
Source: SafetyLit - May 12, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Advanced Catheter Therapies Signs Worldwide License Agreement With Toray Industries, Inc. for the Occlusion Perfusion Catheter(R)
CHATTANOOGA, TN--(Healthcare Sales & Marketing Network) - Advanced Catheter Therapies, Inc. (ACT) announced today that it has signed a worldwide License Agreement with Toray Industries, Inc. (TORAY) to manufacture, market and sell the patented and FDA-cle... Devices, Interventional, Licensing, DistributionAdvanced Catheter Therapies, Toray Industries, Occlusion Perfusion Catheter
Source: HSMN NewsFeed - April 19, 2016 Category: Pharmaceuticals Source Type: news

Cutaneous Lupus Erythematosus: An UpdateCutaneous Lupus Erythematosus: An Update
What is the current understanding regarding the immunopathogenesis of cutaneous lupus erythematosus? Read about the latest efforts to define CLE, as well as available treatments, in this update. American Journal of Clinical Dermatology
Source: Medscape Today Headlines - April 13, 2016 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING (Avobenzone, Octinoxate, Octocrylene, And Oxybenzone) Cream SHISEIDO AMERICAS CORPORATION
Updated Date: Feb 1, 2016 EST
Source: DailyMed Drug Label Updates - February 1, 2016 Category: Drugs & Pharmacology Source Type: alerts

CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING (Avobenzone, Octinoxate, Octocrylene, And Oxybenzone) Emulsion SHISEIDO AMERICAS CORPORATION
Updated Date: Feb 1, 2016 EST
Source: DailyMed Drug Label Updates - February 1, 2016 Category: Drugs & Pharmacology Source Type: alerts

Mauna Kea Technologies, Cook Medical Agree To Global Commercialization Partnership
Mauna Kea Technologies, inventor of Cellvizio, the multi-disciplinary confocal laser endomicroscopy (CLE) platform, announced today it has entered into a global commercialization partnership with Cook Medical for urology applications of its unique Cellvizio platform.
Source: Medical Design Online News - December 11, 2015 Category: Medical Equipment Source Type: news

Photo Release -- The Negotiation Institute Announces the Women’s Insights on the Art of Negotiating (WIN) Summit Qualifies for 11 Continuing Legal Education (CLE) Credits
Source: Medical News (via PRIMEZONE) - August 4, 2015 Category: Pharmaceuticals Source Type: news

Pages: 1 2 3 4 5 6